Dana Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.73M Buy
47,626
+2,665
+6% +$308K 0.17% 153
2025
Q4
$4.73M Sell
44,961
-94
-0.2% -$8.82K 0.14% 173
2025
Q3
$3.78M Buy
45,055
+2,825
+7% +$233K 0.11% 202
2025
Q2
$3.34M Sell
42,230
-3,199
-7% -$254K 0.11% 212
2025
Q1
$4.08M Sell
45,429
-96,599
-68% -$9.02M 0.15% 177
2024
Q4
$14.1M Sell
142,028
-34,691
-20% -$3.58M 0.47% 43
2024
Q3
$20.1M Sell
176,719
-3,946
-2% -$469K 0.66% 34
2024
Q2
$22.4M Sell
180,665
-10,098
-5% -$1.3M 0.76% 25
2024
Q1
$25.2M Buy
190,763
+6,474
+4% +$798K 0.84% 20
2023
Q4
$20.1M Sell
184,289
-24,140
-12% -$2.51M 0.97% 27
2023
Q3
$21.5M Buy
208,429
+36,585
+21% +$3.94M 1.1% 20
2023
Q2
$19.8M Sell
171,844
-13,105
-7% -$1.49M 0.98% 30
2023
Q1
$19.7M Sell
184,949
-22,685
-11% -$2.45M 1% 34
2022
Q4
$23M Sell
207,634
-8,163
-4% -$834K 1.21% 27
2022
Q3
$18.6M Sell
215,797
-35,600
-14% -$3.18M 1.05% 32
2022
Q2
$22.9M Sell
251,397
-27,153
-10% -$2.41M 1.16% 27
2022
Q1
$22.9M Buy
278,550
+85,094
+44% +$6.71M 1.05% 36
2021
Q4
$14.8M Buy
193,456
+150,881
+354% +$12M 0.64% 56
2021
Q3
$3.2M Buy
42,575
+1,167
+3% +$88.8K 0.14% 99
2021
Q2
$3.22M Buy
41,408
+3,368
+9% +$251K 0.14% 101
2021
Q1
$2.8M Sell
38,040
-255,938
-87% -$18.9M 0.13% 109
2020
Q4
$22.9M Buy
293,978
+20,071
+7% +$1.54M 1.14% 32
2020
Q3
$21.7M Sell
273,907
-28,957
-10% -$2.27M 1.18% 32
2020
Q2
$22.3M Sell
302,864
-34,383
-10% -$2.59M 1.21% 32
2020
Q1
$24.8M Buy
337,247
+4,772
+1% +$375K 1.51% 22
2019
Q4
$28.9M Buy
332,475
+11,592
+4% +$952K 1.38% 33
2019
Q3
$25.8M Buy
320,883
+10,308
+3% +$826K 1.31% 37
2019
Q2
$24.8M Buy
310,575
+73
+0% +$5.59K 1.23% 31
2019
Q1
$24.6M Buy
310,502
+204,755
+194% +$15.3M 1.16% 35
2018
Q4
$7.71M Buy
+105,747
New +$7.47M 0.39% 79
2013
Q4
Sell
-47,358
Closed -$2.15M 277
2013
Q3
$2.15M Buy
47,358
+424
+0.9% +$19.4K 0.15% 107
2013
Q2
$2.08M Buy
+46,934
New +$2.1M 0.16% 112

Other funds holding MRK

Dana Investment Advisors's MRK Position: Q1 2026 in Review

Dana Investment Advisors increased its Merck (MRK) stake by 5.9% in Q1 2026, buying an estimated $308K and bringing the position to 47,626 shares worth $5.73M. The position accounts for 0.17% of the portfolio, ranked #153.

Dana Investment Advisors first reported a position in MRK in Q2 2013 and has held it in 32 quarters since. The position peaked at $28.9M in Q4 2019. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Dana Investment Advisors held 47,626 shares of Merck worth $5.73M as of Q1 2026.
  • Dana Investment Advisors bought 2,665 Merck shares in Q1 2026, an estimated $308K.
  • Merck made up 0.17% of Dana Investment Advisors's portfolio in Q1 2026, its #153 holding.
  • Dana Investment Advisors first reported a position in Merck in Q2 2013 and has held it in 32 quarters since.
  • Dana Investment Advisors's Merck position peaked at $28.9M in Q4 2019.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Dana Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.